Protai bio

General Data

supplementary funding
Reg Number
516427895
Sector
Biomed
Established
2021
No. of Employees
25
Stage
R&D
Additional Funding
1

Description

Drug discovery startup based on Proteomics and AI

Technology

Protai's technology analyzes the proteins, their activity and the interactions between them, thus it can predict which changes in the protein will lead to the suitable effect for curing a disease and deduce from this how to develop a suitable drug.

Targeted Customers

Physicians.

Management personnel

Eran Seger - CEO & Co-Founder
[email protected]
Kirill Pevzner - CTO & Co-Founder
[email protected]

Contact information

Name
Eran Seger
Email
[email protected]
Phone
0545313399
Website
https://www.protai.bio
Country
Israel
Zip
5320047

Tags

Artificial IntelligenceBiomedicalBiotechnologyComputational BiologyDrug DiscoveryHealthtechLife SciencesMachine LearningMedTechProteomics

Classified Technologies

Pharma

Winning details

Route name
Winning year

Applied Research Consortia - Applied Research Fund
Applied Research Consortia - Applied Research Fund
2024
Applied Research Consortia - Applied Research Fund
Applied Research Consortia - Applied Research Fund
2026
To the full list